Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shenghui Tang

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
The Oncologist|February 13, 2024
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical TrialsJonathon Vallejo, Harpreet Singh, Erin Larkins, et al.
JAMA Oncology|June 16, 2017
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysisGideon M Blumenthal, Lijun Zhang, Hui Zhang, et al.
Pediatrics|October 7, 2004
Validation of a multistage asthma case-detection procedure for elementary school childrenLynn B Gerald, Roni Grad, Anne Turner-Henson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analysesGideon M Blumenthal, Stella W Karuri, Hui Zhang, et al.
Journal of the National Cancer Institute|March 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysisJaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2026
FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric CancerSandra J Casak, Yiming Zhang, Chi Song, et al.
Journal for Immunotherapy of Cancer|February 16, 2023
Regulatory implications of ctDNA in immuno-oncology for solid tumorsPaz J Vellanki, Soma Ghosh, Anand Pathak, et al.
JAMA|February 28, 2002
Predictive model to identify positive tuberculosis skin test results during contact investigationsWilliam C Bailey, Lynn B Gerald, Michael E Kimerling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2019
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast CancerSuparna Wedam, Lola Fashoyin-Aje, Erik Bloomquist, et al.
The Journal of School Health|August 22, 2006
Allergens in school settings: results of environmental assessments in 3 city school systemsStuart L Abramson, Anne Turner-Henson, Lise Anderson, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
The Oncologist|February 13, 2024
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical TrialsJonathon Vallejo, Harpreet Singh, Erin Larkins, et al.
JAMA Oncology|June 16, 2017
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysisGideon M Blumenthal, Lijun Zhang, Hui Zhang, et al.
Pediatrics|October 7, 2004
Validation of a multistage asthma case-detection procedure for elementary school childrenLynn B Gerald, Roni Grad, Anne Turner-Henson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analysesGideon M Blumenthal, Stella W Karuri, Hui Zhang, et al.
Journal of the National Cancer Institute|March 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysisJaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2026
FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric CancerSandra J Casak, Yiming Zhang, Chi Song, et al.
Journal for Immunotherapy of Cancer|February 16, 2023
Regulatory implications of ctDNA in immuno-oncology for solid tumorsPaz J Vellanki, Soma Ghosh, Anand Pathak, et al.
JAMA|February 28, 2002
Predictive model to identify positive tuberculosis skin test results during contact investigationsWilliam C Bailey, Lynn B Gerald, Michael E Kimerling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2019
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast CancerSuparna Wedam, Lola Fashoyin-Aje, Erik Bloomquist, et al.
The Journal of School Health|August 22, 2006
Allergens in school settings: results of environmental assessments in 3 city school systemsStuart L Abramson, Anne Turner-Henson, Lise Anderson, et al.
Pageof 12